Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
Study NCT ID:
NCT00793156
Status:
UNKNOWN
Last Update Posted:
2010-02-04
First Post:
2008-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Sponsor:
Acologix, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-03
Completion Date Type:
ESTIMATED
First Submit Date:
2008-11-17
First Submit QC Date:
None
Study First Post Date:
2008-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-02-03
Last Update Post Date:
2010-02-04
Last Update Post Date Type:
ESTIMATED